Trading Capital and Board-Finance Oversight Adviser

The mandate

The finance committee's standing question is which commodity-trading opportunities deserve capital once collateral volatility, cash timing and entity constraints are considered alongside expected contribution. A headline return on trading capital may hide a funding burden that materialises under stress. The adviser will test allocation and oversight evidence, not predict commodity prices or recommend individual trades.

Four monthly days are reserved for capital-paper analysis, treasury and trading-finance interviews and a written challenge session. Scheduled finance committee attendance is included. Papers arrive six working days in advance; urgent questions receive acknowledgement within one business day and a considered reply within three when records are available. Live trading support and facility negotiation require different executive or professional arrangements.

The review calendar spans nine months from 19 October 2026. Renewal is a finance committee chair decision tied to unresolved allocation or governance questions and continuing independence. Mumbai is the India base for remote preparation and prearranged workshops. The adviser should leave stronger internal capital questions and evidence conventions rather than become an unofficial standing member of the trading decision chain.

This oversight retainer gives no line authority to instruct traders, treasury or entity administrators. The adviser assumes no executive responsibility for capital release, trade exposure or legal-entity decisions. The committee owns allocation, management executes and appointed professionals supply legal or statutory conclusions. Advice must make the cash and collateral downside visible when an attractive base-case return depends on favourable market timing.

Concurrent retainers are acceptable outside competing trades or reviewed financing counterparties. An economic interest in a proposed trading partner, a capital-arranging commission or paid authorship of the reviewed business case creates a conflict. Relationships and fee dependencies must be disclosed before access, with recusal where necessary. Confidential exposure and governance records cannot support another counterparty's negotiation or investment proposal.

What you will own

• Test capital proposals against cash and collateral stress, separating expected trading contribution from the funding capacity required to hold or settle the exposure.
• Question allocation papers on entity limits and approval dependencies before the committee treats regional capital as immediately deployable across all reviewed opportunities.
• Shape comparable alternatives showing opportunity cost, liquidity burden and reversibility, making deferral or staged commitment visible alongside the proposed full-capital option.
• Press finance and treasury owners to substantiate collateral assumptions with records and approved facility conditions rather than convenient percentages applied to nominal exposure.
• Challenge board-finance papers for traceable approvals and residual-risk ownership, identifying where administrative completion is being mistaken for an authorised capital or entity decision.
• Recommend review triggers for allocation and oversight that remain useful under adverse price or cash timing, leaving execution and trading-risk acceptance with internal leaders.

Candidate qualifications

• Demonstrate eighteen-plus years in finance with senior country or regional responsibility in commodities, trading or natural-resource businesses. Present a capital allocation recommendation you challenged, the cash or collateral assumption changed and the decision influenced. Describe the entity restriction or facility condition that changed your recommendation, including the evidence needed before the committee could rely on a proposed capital release.
• Show practical understanding of commodity working capital, settlement and collateral, with a case where return and funding burden pointed to different choices. Explain the source records and downside assumptions you tested, and distinguish finance advice from authority to set trading limits or choose positions.
• Bring board-finance oversight and entity-governance experience supported by a clear approval and evidence trail. Provide an example where the apparent completion of a paper did not establish valid approval, and show how you preserved statutory or legal responsibility while improving committee decision quality.
• Prove independent advisory conduct with counterparty, lender or transaction-fee conflicts managed in practice. Disclose relevant current interests and demonstrate the capacity for four reserved days monthly. The adviser must provide concise challenge, record rejected advice and protect confidential exposure data without assuming executive capital-release, trading or company-secretarial powers.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 13 October 2026. Mandate reference PCT-ADV-2026-IND-56.